Skip to main content
Erschienen in: Applied Health Economics and Health Policy 1/2006

01.03.2006 | Review Article

Methodological aspects in the assessment of treatment effects in observational health outcomes studies

verfasst von: Josep Maria Haro, Stathis Kontodimas, Miguel Angel Negrin, Mark Ratcliffe, David Suarez, Frank Windmeijer

Erschienen in: Applied Health Economics and Health Policy | Ausgabe 1/2006

Einloggen, um Zugang zu erhalten

Abstract

Prospective observational studies, which provide information on the effectiveness of interventions in natural settings, may complement results from randomised clinical trials in the evaluation of health technologies. However, observational studies are subject to a number of potential methodological weaknesses, mainly selection and observer bias. This paper reviews and applies various methods to control for selection bias in the estimation of treatment effects and proposes novel ways to assess the presence of observer bias. We also address the issues of estimation and inference in a multilevel setting. We describe and compare the use of regression methods, propensity score matching, fixed-effects models incorporating investigator characteristics, and a multilevel, hierarchical model using Bayesian estimation techniques in the control of selection bias. We also propose to assess the existence of observer bias in observational studies by comparing patient- and investigator-reported outcomes. To illustrate these methods, we have used data from the SOHO (Schizophrenia Outpatient Health Outcomes) study, a large, prospective, observational study of health outcomes associated with the treatment of schizophrenia.
The methods used to adjust for differences between treatment groups that could cause selection bias yielded comparable results, reinforcing the validity of the findings. Also, the assessment of observer bias did not show that it existed in the SOHO study. Observational studies, when properly conducted and when using adequate statistical methods, can provide valid information on the evaluation of health technologies.
Literatur
1.
Zurück zum Zitat Hofer A, Hummer M, Huber R, et al. Selection bias in clinical trials with antipsychotics. J Clin Psychopharmacol 2000; 20: 699–702PubMedCrossRef Hofer A, Hummer M, Huber R, et al. Selection bias in clinical trials with antipsychotics. J Clin Psychopharmacol 2000; 20: 699–702PubMedCrossRef
2.
Zurück zum Zitat Wells KB. Treatment research at the crossroads: the scientific interface of clinical trials and effectiveness research. Am J Psychiatry 1999; 156: 5–10PubMed Wells KB. Treatment research at the crossroads: the scientific interface of clinical trials and effectiveness research. Am J Psychiatry 1999; 156: 5–10PubMed
3.
Zurück zum Zitat Rubin DB. Estimating causal effects from large data sets using propensity scores. Ann Intern Med 1997; 127(8 Pt 2): 757–63PubMed Rubin DB. Estimating causal effects from large data sets using propensity scores. Ann Intern Med 1997; 127(8 Pt 2): 757–63PubMed
4.
Zurück zum Zitat Concato J, Shah N, Horwitz RI. Randomised, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med 2000 Jun 22; 342(25): 1887–92PubMedCrossRef Concato J, Shah N, Horwitz RI. Randomised, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med 2000 Jun 22; 342(25): 1887–92PubMedCrossRef
5.
Zurück zum Zitat Benson K, Hartz AJ. A comparison of observational studies and randomised, controlled trials. N Engl J Med 2000 Jun 22; 342(25): 1878–86PubMedCrossRef Benson K, Hartz AJ. A comparison of observational studies and randomised, controlled trials. N Engl J Med 2000 Jun 22; 342(25): 1878–86PubMedCrossRef
6.
Zurück zum Zitat Black N. Why we need observational studies to evaluate the effectiveness of healthcare. BMJ 1996 May 11; 312(7040): 1215–8PubMedCrossRef Black N. Why we need observational studies to evaluate the effectiveness of healthcare. BMJ 1996 May 11; 312(7040): 1215–8PubMedCrossRef
7.
Zurück zum Zitat Black N. What observational studies can offer decision makers. Horm Res. 1999; 51 Suppl. 1: 44–9PubMedCrossRef Black N. What observational studies can offer decision makers. Horm Res. 1999; 51 Suppl. 1: 44–9PubMedCrossRef
8.
Zurück zum Zitat Britton A, McPherson K, McKee M, et al. Choosing between randomised and non-randomised studies: a systematic review. Health Technol Assess 1998; 2(13): I–iv, 1-124PubMed Britton A, McPherson K, McKee M, et al. Choosing between randomised and non-randomised studies: a systematic review. Health Technol Assess 1998; 2(13): I–iv, 1-124PubMed
9.
Zurück zum Zitat Pocock SJ, Elbourne DR. Randomised trials or observational tribulations? N Engl J Med 2000 Jun 22; 342(25): 1907–9PubMedCrossRef Pocock SJ, Elbourne DR. Randomised trials or observational tribulations? N Engl J Med 2000 Jun 22; 342(25): 1907–9PubMedCrossRef
10.
Zurück zum Zitat Friedman HS. Observational studies and randomised trials [letter]. N Engl J Med 2000 Oct 19; 343(16): 1195–6PubMed Friedman HS. Observational studies and randomised trials [letter]. N Engl J Med 2000 Oct 19; 343(16): 1195–6PubMed
11.
Zurück zum Zitat Kunz R, Khan KS, Neumayer HH. Observational studies and randomised trials [letter]. N Engl J Med 2000 Oct 19; 343(16): 1194–5PubMedCrossRef Kunz R, Khan KS, Neumayer HH. Observational studies and randomised trials [letter]. N Engl J Med 2000 Oct 19; 343(16): 1194–5PubMedCrossRef
12.
Zurück zum Zitat Sacks HS. Observational studies and randomised trials [letter]. N Engl J Med 2000 Oct 19; 343(16): 1195PubMed Sacks HS. Observational studies and randomised trials [letter]. N Engl J Med 2000 Oct 19; 343(16): 1195PubMed
13.
Zurück zum Zitat Liu PY, Anderson G, Crowley JJ. Observational studies and randomised trials [letter]. N Engl J Med 2000 Oct 19; 343(16): 1195PubMed Liu PY, Anderson G, Crowley JJ. Observational studies and randomised trials [letter]. N Engl J Med 2000 Oct 19; 343(16): 1195PubMed
14.
Zurück zum Zitat Smith RP, Meier P. Observational studies and randomised trials [letter]. N Engl J Med 2000 Oct 19; 343(16): 1196PubMed Smith RP, Meier P. Observational studies and randomised trials [letter]. N Engl J Med 2000 Oct 19; 343(16): 1196PubMed
15.
Zurück zum Zitat Hlatky MA, Califf RM, Harrell Jr FE, et al. Comparison of predictions based on observational data with the results of randomised controlled clinical trials of coronary artery bypass surgery. J Am Coll Cardiol 1988; 11: 237–45PubMedCrossRef Hlatky MA, Califf RM, Harrell Jr FE, et al. Comparison of predictions based on observational data with the results of randomised controlled clinical trials of coronary artery bypass surgery. J Am Coll Cardiol 1988; 11: 237–45PubMedCrossRef
16.
Zurück zum Zitat Kunz R, Oxman AD. The unpredictability paradox: review of empirical comparisons of randomised and non-randomised clinical trials. BMJ 1998; 317: 1185–90PubMedCrossRef Kunz R, Oxman AD. The unpredictability paradox: review of empirical comparisons of randomised and non-randomised clinical trials. BMJ 1998; 317: 1185–90PubMedCrossRef
17.
Zurück zum Zitat Wolfe RA. Observational studies are just as effective as randomised clinical trials. Blood Purif 2000; 18(4): 323–6PubMedCrossRef Wolfe RA. Observational studies are just as effective as randomised clinical trials. Blood Purif 2000; 18(4): 323–6PubMedCrossRef
18.
Zurück zum Zitat Greene T. Are observational studies ‘just as effective’ as randomised clinical trials? Blood Purif 2000; 18(4): 317–22PubMedCrossRef Greene T. Are observational studies ‘just as effective’ as randomised clinical trials? Blood Purif 2000; 18(4): 317–22PubMedCrossRef
19.
Zurück zum Zitat Vineis P. Proof in observational medicine. J Epidemiol Commun Health 1997; 51: 9–13CrossRef Vineis P. Proof in observational medicine. J Epidemiol Commun Health 1997; 51: 9–13CrossRef
20.
Zurück zum Zitat Holmberg L, Baum M, Adami HO. On the scientific inference from clinical trials. J Eval Clin Pract 1999 May; 5(2): 157–62PubMedCrossRef Holmberg L, Baum M, Adami HO. On the scientific inference from clinical trials. J Eval Clin Pract 1999 May; 5(2): 157–62PubMedCrossRef
21.
Zurück zum Zitat Wilson GT. The clinical utility of randomised controlled trials. Int J Eat Disord 1998 Jul; 24(1): 13–29PubMedCrossRef Wilson GT. The clinical utility of randomised controlled trials. Int J Eat Disord 1998 Jul; 24(1): 13–29PubMedCrossRef
22.
Zurück zum Zitat Ellenberg JH. Selection bias in observational and experimental studies. Stat Med 1994 Mar 15-Apr 15; 13(5–7): 557–67PubMedCrossRef Ellenberg JH. Selection bias in observational and experimental studies. Stat Med 1994 Mar 15-Apr 15; 13(5–7): 557–67PubMedCrossRef
23.
Zurück zum Zitat Kemler MA, de Vet HC. Does randomisation introduce bias in unblinded trials? Epidemiology 2000 Mar; 11(2): 228PubMedCrossRef Kemler MA, de Vet HC. Does randomisation introduce bias in unblinded trials? Epidemiology 2000 Mar; 11(2): 228PubMedCrossRef
24.
Zurück zum Zitat Rabeneck L, Viscoli CM, Horwitz RI. Problems in the conduct and analysis of randomised clinical trials. Are we getting the right answers to the wrong questions? Arch Intern Med 1992 Mar; 152(3): 507–12PubMedCrossRef Rabeneck L, Viscoli CM, Horwitz RI. Problems in the conduct and analysis of randomised clinical trials. Are we getting the right answers to the wrong questions? Arch Intern Med 1992 Mar; 152(3): 507–12PubMedCrossRef
25.
Zurück zum Zitat Caplan LR. Is the promise of randomised control trials (“evidence-based medicine”) overstated? Curr Neurol Neurosci Rep 2002; 2: 1–8PubMedCrossRef Caplan LR. Is the promise of randomised control trials (“evidence-based medicine”) overstated? Curr Neurol Neurosci Rep 2002; 2: 1–8PubMedCrossRef
26.
Zurück zum Zitat Haro JM, Edgell ET, Jones PB, et al. The European Schizophrenia Outpatient Health Outcome (SOHO) study: rationale, methods and recruitment. Acta Psychiatr Scand 2003; 107: 222–32PubMedCrossRef Haro JM, Edgell ET, Jones PB, et al. The European Schizophrenia Outpatient Health Outcome (SOHO) study: rationale, methods and recruitment. Acta Psychiatr Scand 2003; 107: 222–32PubMedCrossRef
27.
Zurück zum Zitat Haro JM, Edgell ET, Frewer P, et al. The European Schizophrenia Outpatient Health Outcomes (SOHO) study: baseline findings across country and treatment. Acta Psychiatr Scand Suppl 2003; 416: 7–15PubMedCrossRef Haro JM, Edgell ET, Frewer P, et al. The European Schizophrenia Outpatient Health Outcomes (SOHO) study: baseline findings across country and treatment. Acta Psychiatr Scand Suppl 2003; 416: 7–15PubMedCrossRef
28.
Zurück zum Zitat Haro JM, Edgell ET, Novick D, et al. Effectiveness of antip-sychotic treatment for schizophrenia: 6-month results of the pan-European Schizophrenia Outpatient Health Outcomes (SOHO) study. Acta Psychiatr Scand 2005; 111: 220–31PubMedCrossRef Haro JM, Edgell ET, Novick D, et al. Effectiveness of antip-sychotic treatment for schizophrenia: 6-month results of the pan-European Schizophrenia Outpatient Health Outcomes (SOHO) study. Acta Psychiatr Scand 2005; 111: 220–31PubMedCrossRef
29.
Zurück zum Zitat Haro JM, Kamath SA, Ochoa S, et al. The clinical global impression-schizophrenia (CGI-SCH) scale: a simple instrument to measure the diversity of symptoms present in schizophrenia. Acta Psychiatr Scand Suppl 2003; 416: 16–23PubMedCrossRef Haro JM, Kamath SA, Ochoa S, et al. The clinical global impression-schizophrenia (CGI-SCH) scale: a simple instrument to measure the diversity of symptoms present in schizophrenia. Acta Psychiatr Scand Suppl 2003; 416: 16–23PubMedCrossRef
30.
Zurück zum Zitat Guy W. Clinical global impression. In: Guy W, editor. ECDEU assessment manual for psychopharmacology, revised. Rock-ville (MD): National Institute of Mental Health, 1976: 217–22 Guy W. Clinical global impression. In: Guy W, editor. ECDEU assessment manual for psychopharmacology, revised. Rock-ville (MD): National Institute of Mental Health, 1976: 217–22
31.
Zurück zum Zitat Williams A. EuroQol: a new facility for the measurement of health-related quality of life. Health Policy 1990; 16: 199–208CrossRef Williams A. EuroQol: a new facility for the measurement of health-related quality of life. Health Policy 1990; 16: 199–208CrossRef
32.
Zurück zum Zitat Kind P, Hardman G, Macran S. UK population norms for EQ-5D. York Centre for Health Economics Discussion Paper, 172. York: Centre for Health Economics, University of York, 1999 Kind P, Hardman G, Macran S. UK population norms for EQ-5D. York Centre for Health Economics Discussion Paper, 172. York: Centre for Health Economics, University of York, 1999
33.
Zurück zum Zitat Lambert M, Haro JM, Novick D, et al. Olanzapine vs. other antipsychotics in actual out-patient settings: six months tolera-bility results from the European Schizophrenia Out-patient Health Outcomes study. Acta Psychiatr Scand 2005; 111: 232–43PubMedCrossRef Lambert M, Haro JM, Novick D, et al. Olanzapine vs. other antipsychotics in actual out-patient settings: six months tolera-bility results from the European Schizophrenia Out-patient Health Outcomes study. Acta Psychiatr Scand 2005; 111: 232–43PubMedCrossRef
34.
Zurück zum Zitat Rosenbaum PR. Observational studies. 2nd ed. New York: Springer-Verlag, 2002 Rosenbaum PR. Observational studies. 2nd ed. New York: Springer-Verlag, 2002
35.
Zurück zum Zitat Starr TB, Dalcorso RD, Levine RJ. Fertility of workers: a comparison of logistic regression and indirect standardization. Am J Epidemiol 1986; 123: 490–8PubMed Starr TB, Dalcorso RD, Levine RJ. Fertility of workers: a comparison of logistic regression and indirect standardization. Am J Epidemiol 1986; 123: 490–8PubMed
36.
Zurück zum Zitat Altman DG. Comparability of randomised groups. Statistician 1985; 34: 125–36CrossRef Altman DG. Comparability of randomised groups. Statistician 1985; 34: 125–36CrossRef
37.
Zurück zum Zitat Rubin DB, Thomas N. Matching using estimated propensity scores: relating theory to practice. Biometrics 1996; 52: 249–64PubMedCrossRef Rubin DB, Thomas N. Matching using estimated propensity scores: relating theory to practice. Biometrics 1996; 52: 249–64PubMedCrossRef
38.
Zurück zum Zitat Cochrane WG. The effectiveness of adjustment by subclassification in removing bias in observational studies. Biometrics 1968; 24: 295–313CrossRef Cochrane WG. The effectiveness of adjustment by subclassification in removing bias in observational studies. Biometrics 1968; 24: 295–313CrossRef
39.
Zurück zum Zitat Drake C. Effects of misspecifications of the propensity score on estimators of treatment effects. Biometrics 1993; 49: 1231–6CrossRef Drake C. Effects of misspecifications of the propensity score on estimators of treatment effects. Biometrics 1993; 49: 1231–6CrossRef
40.
Zurück zum Zitat Hylan TR, Crown WH, Meneades L, et al. Tricyclic antidepres-sant and selective serotonin reuptake inhibitors antidepressant selection and health care costs in the naturalistic setting: a multivariate analysis. J Affect Disord 1998; 47: 71–9PubMedCrossRef Hylan TR, Crown WH, Meneades L, et al. Tricyclic antidepres-sant and selective serotonin reuptake inhibitors antidepressant selection and health care costs in the naturalistic setting: a multivariate analysis. J Affect Disord 1998; 47: 71–9PubMedCrossRef
41.
Zurück zum Zitat Lu M. The productivity of mental health care: an instrumental variable approach. J Ment Health Policy Econ 1999; 2: 59–71PubMedCrossRef Lu M. The productivity of mental health care: an instrumental variable approach. J Ment Health Policy Econ 1999; 2: 59–71PubMedCrossRef
42.
Zurück zum Zitat Salkever DS, Slade EP, Karakus M, et al. Estimation of antip-sychotic effects of hospitalisation risk in a naturalistic study with selection of unobservables. J Nerv Ment Dis 2004; 192: 119–28PubMedCrossRef Salkever DS, Slade EP, Karakus M, et al. Estimation of antip-sychotic effects of hospitalisation risk in a naturalistic study with selection of unobservables. J Nerv Ment Dis 2004; 192: 119–28PubMedCrossRef
43.
Zurück zum Zitat Hadley J, Polsky D, Mandelblatt JS, et al. An exploratory instrumental variable analysis of the outcomes of localized breast cancer treatments in a Medicare population. Health Econ 2003; 12: 171–86PubMedCrossRef Hadley J, Polsky D, Mandelblatt JS, et al. An exploratory instrumental variable analysis of the outcomes of localized breast cancer treatments in a Medicare population. Health Econ 2003; 12: 171–86PubMedCrossRef
44.
Zurück zum Zitat Bound J, Jaeger DA, Baker RM. Problems with instrumental variables estimation when the correlation between the instruments and the endogenous explanatory variable is weak. J Am Stat Assoc 1995; 90: 443–50 Bound J, Jaeger DA, Baker RM. Problems with instrumental variables estimation when the correlation between the instruments and the endogenous explanatory variable is weak. J Am Stat Assoc 1995; 90: 443–50
45.
Zurück zum Zitat Heckman JJ. Sample specification bias as a specification error. Econometrica 1979; 47: 153–61CrossRef Heckman JJ. Sample specification bias as a specification error. Econometrica 1979; 47: 153–61CrossRef
46.
Zurück zum Zitat Wooldridge JM. Econometric analysis of cross section and panel data. Cambridge (MA): MIT Press, 2002 Wooldridge JM. Econometric analysis of cross section and panel data. Cambridge (MA): MIT Press, 2002
47.
Zurück zum Zitat Lee M-J. Panel data econometrics: method-of-moments and limited dependent variables. San Diego (CA): Academic Press, 2002 Lee M-J. Panel data econometrics: method-of-moments and limited dependent variables. San Diego (CA): Academic Press, 2002
48.
Zurück zum Zitat Spiegelhalter DJ, Feedman LS, Parmar MKB. Bayesian approaches to randomized trials (with discussion). J R Stat Soc Ser A Stat Soc 1994; 157: 357–416CrossRef Spiegelhalter DJ, Feedman LS, Parmar MKB. Bayesian approaches to randomized trials (with discussion). J R Stat Soc Ser A Stat Soc 1994; 157: 357–416CrossRef
49.
Zurück zum Zitat Jones DA. A Bayesian approach to the economic evaluation of health care technologies. In: Spiker B, editor. Quality of life and pharmaeconomics in clinical trials. 2nd ed. Philadelphia (PA): Lippincott-Raven, 1996: 1189–96 Jones DA. A Bayesian approach to the economic evaluation of health care technologies. In: Spiker B, editor. Quality of life and pharmaeconomics in clinical trials. 2nd ed. Philadelphia (PA): Lippincott-Raven, 1996: 1189–96
50.
Zurück zum Zitat Sculpher MJ, Pang FS, Manca A, et al. Generalisability in economic evaluation studies in health care: a review and case-studies. Health Technol Assess 2004; 8: 1–206 Sculpher MJ, Pang FS, Manca A, et al. Generalisability in economic evaluation studies in health care: a review and case-studies. Health Technol Assess 2004; 8: 1–206
51.
Zurück zum Zitat Rice N, Leyland A. Multilevel models: applications to health data. J Health Serv Res Policy 1996; 1: 154–64PubMed Rice N, Leyland A. Multilevel models: applications to health data. J Health Serv Res Policy 1996; 1: 154–64PubMed
52.
Zurück zum Zitat Leyland AH, Goldstein H. Multilevel modelling of health statistics. Chichester: Willey, 2001 Leyland AH, Goldstein H. Multilevel modelling of health statistics. Chichester: Willey, 2001
53.
Zurück zum Zitat Goldstein H, Browne W, Rasbash J. Multilevel modelling of medical data. Stat Med 2002; 21: 3291–315PubMedCrossRef Goldstein H, Browne W, Rasbash J. Multilevel modelling of medical data. Stat Med 2002; 21: 3291–315PubMedCrossRef
54.
Zurück zum Zitat Manca A, Rice N, Sculpher MJ, et al. Assessing generalisability by location in trial-based cost-effectiveness analysis: the use of multilevel models [published erratum appears in Health Econ 2005; 14 (5): 486]. Health Econ 2005; 14: 47–85 Manca A, Rice N, Sculpher MJ, et al. Assessing generalisability by location in trial-based cost-effectiveness analysis: the use of multilevel models [published erratum appears in Health Econ 2005; 14 (5): 486]. Health Econ 2005; 14: 47–85
55.
Zurück zum Zitat Grieve R, Nixon R, Thompson SG, et al. Using multilevel models for assessing the variability of multinational resource use and cost data. Health Econ 2005; 14: 185–96PubMedCrossRef Grieve R, Nixon R, Thompson SG, et al. Using multilevel models for assessing the variability of multinational resource use and cost data. Health Econ 2005; 14: 185–96PubMedCrossRef
56.
Zurück zum Zitat Chien CF, Steinwachs DM, Lehman A, et al. Provider continuity and outcomes of care for persons with schizophrenia. Ment Health Serv Res 2000; 2: 201–11CrossRef Chien CF, Steinwachs DM, Lehman A, et al. Provider continuity and outcomes of care for persons with schizophrenia. Ment Health Serv Res 2000; 2: 201–11CrossRef
57.
Zurück zum Zitat Haro JM, Salvador-Carulla L, Cabases J, et al. Utilisation of mental health services and costs of patients with schizophrenia in three areas of Spain. Br J Psychiatry 1998; 173: 334–40PubMedCrossRef Haro JM, Salvador-Carulla L, Cabases J, et al. Utilisation of mental health services and costs of patients with schizophrenia in three areas of Spain. Br J Psychiatry 1998; 173: 334–40PubMedCrossRef
Metadaten
Titel
Methodological aspects in the assessment of treatment effects in observational health outcomes studies
verfasst von
Josep Maria Haro
Stathis Kontodimas
Miguel Angel Negrin
Mark Ratcliffe
David Suarez
Frank Windmeijer
Publikationsdatum
01.03.2006
Verlag
Springer International Publishing
Erschienen in
Applied Health Economics and Health Policy / Ausgabe 1/2006
Print ISSN: 1175-5652
Elektronische ISSN: 1179-1896
DOI
https://doi.org/10.2165/00148365-200605010-00003

Weitere Artikel der Ausgabe 1/2006

Applied Health Economics and Health Policy 1/2006 Zur Ausgabe

Current Opinion

Recycling blood